Characteristics of Fluorescent Intraoperative Dyes Helpful in Gross Total Resection of High-Grade Gliomas-A Systematic Review
- PMID: 33339439
- PMCID: PMC7766001
- DOI: 10.3390/diagnostics10121100
Characteristics of Fluorescent Intraoperative Dyes Helpful in Gross Total Resection of High-Grade Gliomas-A Systematic Review
Abstract
Background: A very important aspect in the treatment of high-grade glioma is gross total resection to reduce the risk of tumor recurrence. One of the methods to facilitate this task is intraoperative fluorescence navigation. The aim of the study was to compare the dyes used in this technique fluorescent intraoperative navigation in terms of the mechanism of action and influence on the treatment of patients. Methods: The review was carried out on the basis of articles found in PubMed, Google Scholar, and BMC search engines, as well as those identified by searched bibliographies and suggested by experts during the preparation of the article. The database analysis was performed for the following phrases: "glioma", "glioblastoma", "ALA", "5ALA", "5-ALA", "aminolevulinic acid", "levulinic acid", "fluorescein", "ICG", "indocyanine green", and "fluorescence navigation". Results: After analyzing 913 citations identified on the basis of the search criteria, we included 36 studies in the review. On the basis of the analyzed articles, we found that 5-aminolevulinic acid and fluorescein are highly effective in improving the percentage of gross total resection achieved in high-grade glioma surgery. At the same time, the limitations resulting from the use of these methods are marked-higher costs of the procedure and the need to have neurosurgical microscope in combination with a special light filter in the case of 5-aminolevulinic acid (5-ALA), and low specificity for neoplastic cells and the dependence on the degree of damage to the blood-brain barrier in the intensity of fluorescence in the case of fluorescein. The use of indocyanine green in the visualization of glioma cells is relatively unknown, but some researchers have suggested its utility and the benefits of using it simultaneously with other dyes. Conclusion: The use of intraoperative fluorescence navigation with the use of 5-aminolevulinic acid and fluorescein allows the range of high-grade glioma resection to be increased.
Keywords: 5-aminolevulinic acid; fluorescein; high-grade glioma; indocyanine green.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
5-aminolevulinic acid, fluorescein sodium, and indocyanine green for glioma margin detection: analysis of operating wide-field and confocal microscopy in glioma models of various grades.Front Oncol. 2023 May 23;13:1156812. doi: 10.3389/fonc.2023.1156812. eCollection 2023. Front Oncol. 2023. PMID: 37287908 Free PMC article.
-
A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.J Neurosurg. 2016 May;124(5):1300-9. doi: 10.3171/2015.5.JNS1577. Epub 2015 Nov 6. J Neurosurg. 2016. PMID: 26544781 Clinical Trial.
-
Enhanced resection of primary high-grade gliomas using a combination of intraoperative magnetic resonance imaging and intraoperative fluorescence (5-aminolevulinic acid): A single-centre experience.Neurol India. 2018 May-Jun;66(3):747-752. doi: 10.4103/0028-3886.232334. Neurol India. 2018. PMID: 29766937
-
The impact of 5-aminolevulinic acid on extent of resection in newly diagnosed high grade gliomas: a systematic review and single institutional experience.J Neurooncol. 2019 Feb;141(3):507-515. doi: 10.1007/s11060-018-03061-3. Epub 2018 Dec 1. J Neurooncol. 2019. PMID: 30506501
-
Intraoperative fluorescence-guided resection of high-grade gliomas: a comparison of the present techniques and evolution of future strategies.World Neurosurg. 2014 Jul-Aug;82(1-2):175-85. doi: 10.1016/j.wneu.2013.06.014. Epub 2013 Jul 9. World Neurosurg. 2014. PMID: 23851210 Review.
Cited by
-
Evolving concepts in meningioma management in the era of genomics.Cancer. 2024 Aug 1;130(15):2586-2600. doi: 10.1002/cncr.35279. Epub 2024 May 16. Cancer. 2024. PMID: 38753473 Free PMC article. Review.
-
State-of-the-Art and New Treatment Approaches for Spinal Cord Tumors.Cancers (Basel). 2024 Jun 27;16(13):2360. doi: 10.3390/cancers16132360. Cancers (Basel). 2024. PMID: 39001422 Free PMC article. Review.
-
Multi-Asymmetric Irradiation Method Using a Ring Array to Obtain an Emission-Capable LED Beam Power Effect to Observe Cancer Removal Status in a Surgical Microscope.Diagnostics (Basel). 2023 Nov 20;13(22):3482. doi: 10.3390/diagnostics13223482. Diagnostics (Basel). 2023. PMID: 37998618 Free PMC article.
-
Fluorescein-guided resection of newly diagnosed high-grade glioma: Impact on extent of resection and outcome.Brain Spine. 2022 Nov 9;2:101690. doi: 10.1016/j.bas.2022.101690. eCollection 2022. Brain Spine. 2022. PMID: 36506293 Free PMC article.
-
5-Aminolevulinic Acid False-Positive Rates in Newly Diagnosed and Recurrent Glioblastoma: Do Pseudoprogression and Radionecrosis Play a Role? A Meta-Analysis.Front Oncol. 2022 Feb 17;12:848036. doi: 10.3389/fonc.2022.848036. eCollection 2022. Front Oncol. 2022. PMID: 35252015 Free PMC article.
References
-
- Chapter 5.16. World Cancer Report 2014. World Health Organization; Geneva, Switzerland: 2014.
-
- Visser O., Ardanaz E., Botta L., Sant M., Tavilla A., Minicozzi P., Hackl M., Zielonke N., Oberaigner W., Van Eycken E., et al. Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 study. Eur. J. Cancer. 2015;51:2231–2241. doi: 10.1016/j.ejca.2015.07.032. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources